LDL-cholesterol
Potential of PCSK9 as a new target for the management of LDL cholesterol
... of LDL cholesterol, is one of the cornerstones of its prevention and ...of LDL cholesterol to conventional goals, a sizeable number of patients continue to suffer CV ...of LDL ...
14
Is interleukin-6 the link between low LDL cholesterol and increased non-cardiovascular mortality in the elderly?
... involved, LDL-C was inversely and significantly associated with all-cause mortality; in the remaining 16, no association was ...of LDL-C was inverse and significant in two and null in ...between ...
5
Extracorporeal LDL-Cholesterol Elimination in the Treatment of Severe Familial Hypercholesterolemia
... Plasmapheresis is an example of non-specific and non- selective method. This is an older and well known method of extracorporeal elimination used in haematology (19). The principle consists in removing virtually all ...
5
Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy
... Methods: We applied US Food and Drug Administration (FDA) and insurance eligibility cri- teria for ALI and EVO to 1090 hypercholesterolemic patients serially referred over 3 years who then received ≥ 2 months ...
7
LDL-Cholesterol in Relation to Mortality of Intracerebral Haemorrhage and Hemorrhagic Transformation of Large Artery Thrombotic Stroke
... This is to certify that the dissertation titled “LDL-Cholesterol in relation to mortality of Intracerebral Haemorrhage and Hemorrhagic transformation of Large Artery Thrombotic Stroke” is the bonafide ...
73
LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach?
... borderline LDL cholesterol elevations common in diabetic patients are associ- ated with substantial cardiovascular risk because of their small, dense composi- tion and the high CHD risk already present in ...
6
Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence
... particularly LDL-cholesterol (LDL-C) ...of LDL-C by partly blocking cholesterol ...lower LDL-C by 7 to 10% in different populations, ages and with different ...serum LDL-C ...
7
Achievement of LDL Cholesterol Goal and Adherence to Statin by Diabetes Patients in Kelantan
... National Cholesterol Education Programme-Adult Treatment Plan I to III (NCEP-ATP III) has established LDL cholesterol as a primary target for therapeutic interaction because low-density lipoprotein ...
7
A genetic variant in the LDLRpromoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia
... with LDL-C that, together with the lipoprotein(a) concentration and age, explained ≈ 10% of LDL-C vari- ...3 LDL cholesterol quintile distribution of frequencies of genotypes CT and TT and ...
8
Effect of bull, diluter and LDL-cholesterol concentration on spermatozoa resistance against cold shock
... of LDL concentration infl uence on sperm survivability without specifi cation of extender ...of LDL cholesterol were statistically insignifi cant (P > ...of LDL were insignifi cant (P > ...
7
COMPARATIVE STUDY OF THE ESTIMATION OF LDL CHOLESTEROL BY THE DIRECT METHOD AND FRIEDEWALD EQUATION IN SECONDARY HYPERLIPIDEMIA
... of LDL by Direct method versus Friedewald ...Total Cholesterol (TC), Triglycerides (TG), Low Density Lipoprotein (LDL-C) cholesterol and High density lipoprotein (HDL) cholesterol, ...
5
Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol
... with LDL cholesterol, the circulating miRNA levels may reflect a compensa- tory response to inflammation under hyperlipidemic ...linking LDL choles- terol and circulating miR-126 levels in patients ...
5
Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation
... of cholesterol in the cir- culation. High levels of LDL cholesterol (LDL-c) were associated with a high risk of developing CVD ...of LDL particle size, and the determination of ...
9
The evolution of selective analyses of HDL and LDL cholesterol in clinical and point of care testing
... Cardiovascular disease is a leading cause of death worldwide and is caused by the build up of atherosclerotic plaques in the vasculature. It is now well established that the formation of these plaques is closely related ...
15
LDL-cholesterol signaling induces breast cancer proliferation and invasion
... that LDL-cholesterol (but not HDL-cholesterol) promotes BC cells proliferation, migration and loss of adhesion, hallmarks of the epithelial to mesenchymal ...modeling cholesterol levels showed ...
9
An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes
... in LDL-cholesterol (≥ 25% for 7-14 days) that correlated well with the extent of PCSK9 occupancy by the ...plasma LDL-cholesterol ...in cholesterol and fatty-acid synthesis including ...
18
Nurse-coordinated care improves the achievement of LDL cholesterol targets through more intensive medication titration
... When LDL-C was not on target during the four NCC visits, nurses documented when medication was changed during the NCC visit, and if the treating specialists were consulted and/or patients were referred to treating ...
7
Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients
... The interaction between vascular endothelial cells and tumor cells is an important step in tumor metastasis. When tumor cells enter blood vessels, some of the cells rapidly disappear in the circulatory system and other ...
7
Correlation between LDL cholesterol and C reactive protein among an apparently healthy population in the city of Athens
... with LDL < 130 mg/dL and CRP > 2 mg/L reduced the LDL levels by 50% as well as the ischemic vascular in- cidents approximately by the same ...(normal LDL, increased CRP) would be benefited by ...
5
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy
... our Cholesterol Diagnosis and Treatment center and receiving ≥ 2 months max- imally tolerated LDLC lowering diet-drug therapy with follow up LDLC ≥ 70 mg/dl, to obtain estimates of the percentage of patients with ...
6